MedPath

Role of hysteroscopy in management of persistent mole

Not Applicable
Conditions
Molar Pregnancy.
Hydatidiform mole, unspecified
Registration Number
IRCT201601222576N11
Lead Sponsor
Deputy Research of Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
30
Inclusion Criteria

all patients with persistent mole(residual of pregnancy in trans vaginal sonography and positive hCG after D&C) are recruited in the study.
Exclusion criterion: patients who prefer chemotherapy instead of hysteroscopy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
B-hCG levels decrease. Timepoint: After one week. Method of measurement: ml/Unit/ml.
Secondary Outcome Measures
NameTimeMethod
o residuea of pregnancy after hysteroscopy. Timepoint: After one week. Method of measurement: Trans vaginal sonography.
© Copyright 2025. All Rights Reserved by MedPath